Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-07-03

FDA Approved: FLUPHENAZINE DECANOATE — Original Application (Endo USA, Inc.)

View source ↗

Summary

FDA approves a generic version of fluphenazine decanoate (long-acting injectable antipsychotic) under Original Application (ANDA) by Endo USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine decanoate (Fluphenazine decanoate)

Snippet

ORIG AP for FLUPHENAZINE DECANOATE (FLUPHENAZINE DECANOATE)